申请人:Alnylam Pharmaceuticals, Inc.
公开号:US08158601B2
公开(公告)日:2012-04-17
The invention features a cationic lipid of formula I,
an improved lipid formulation comprising a cationic lipid of formula I and corresponding methods of use.
Also disclosed are targeting lipids, and specific lipid formulations comprising such targeting lipids.
该发明涉及一种公式I的阳离子脂质、包含公式I阳离子脂质的改进脂质配方以及相应的使用方法。本发明还公开了定向脂质和包含此类定向脂质的特定脂质配方。